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ABSTRACT
Objective: The aim of the study was to evaluate the patient’s perception of the events during and after an osteogenic 
alveolar distraction (OAD) procedure
Materials and Methods: A total of fifty-five (55) osteogenic alveolar distraction (OAD) procedures were performed in 
fifty (50) patients, who then were asked to answer ten (10) questions related to the treatment. Six (6) questions made 
reference to predefined values in a Visual Analogical Scale (VAS), three (3) questions could be answered by a predeter-
mined answer, and only one (1)  question had a free answer. 
Results: In 76% of cases, the patient’s description of the sensation felt during the surgery was good and bearable; 84% 
of the patients didn’t feel pain after surgery. 4% of the patients felt pain during the activation period and 58% of the 
patients described the sensation during the activation period as pressure, felt most commonly, at the end of the period, 
and for about 20 minutes (66.6 %). In these cases the most frequently used analgesic was Paracetamol. Also, 46% ex-
pressed having had some difficulty to activate the device, with 10% of them in need of extra help. The presence of the 
activation rod caused discomfort in 52%. Finally, 78% of the patients treated with OAD would undergo this procedure 
again if  it was necessary. A bone graft was performed in 27 out of the 50 treated patients, with 70% of them describing 
the bone graft surgery as more painful than the OAD. 
Conclusion: The OAD technique had a high degree of acceptance among the treated patients, however, some details as 
the interference of the activation rod continue to disturb them.  The acceptance of the OAD technique is much better 
when compared with bone graft surgery technique as a second treatment. 
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INTRODUCTION
Osteogenic Alveolar Distraction (OAD) is a technique based 
on the principles described by Ilizarov, (1,2) who has earned 
the credit for having defined and established the biological 
bases for the clinical use of osteogenic distraction in the 
management of different bone deformities. Block et al. (3,4) 
applied these principles experimentally and were the first 
to publish studies on the use of OAD in animals in 1996. 
The same year, Chin and Toth (5) reported the clinical use 
of OAD as a treatment in alveolar ridge deficiencies in the 
upper maxillary. 
The OAD is a technique of gradual bone lengthening allo-
wing the body’s natural healing mechanisms to generate 
new bone to augment alveolar ridge height. (6,7). It has the 
ability to enhance osseous and soft tissue deficiencies simul-
taneously, offering a predictable result, with low morbidity 
and infection rates and a significantly shorter healing period 
to proceed with implant’s rehabilitation (12 weeks) when 
compared with traditionally used  methods (6,8,9).
Several studies have been published about the potential 
application and complications of  a vertical distraction 
technique in patients treated with implants (7,9-13), with 
a few of them having described the patient’s perception of 
the procedure (14-18). Nevertheless, no study has been pu-
blished that shows the subjective patient’s perception of the 
surgical procedure, during the surgery and in the immediate 
postoperative days.
The aim of the present prospective study was to evaluate the 
patient’s perception of the events during and after alveolar 
reconstruction using the osteogenic alveolar distraction 
(OAD) technique.
MATERIALS AND METHODS
Fifty patients (33 women and 17 men; Age range: 19 to 66 
years and a Mean age of 42 years ±13.49 SD) were submitted 
to an alveolar reconstruction procedure using the osteogenic 
alveolar distraction (ODA). 
The patients underwent a total of 55 alveolar ridge distrac-
tions using an extraalveolar device Distractor® (Conexão, 
Implant System, São Paulo, Brazil).
In all patients were use the following preoperative protocol: 1 
hour before the surgery Midazolam 15 mg, Dexamethasone 
4 mg and Paracetamol 750 mg. After surgery, all the patients 
used diclofenac potassium 50 mg 8/8 hours for three days, 
paracetamol 750 mg 8/8 hours for three days and amoxicilin 
500mg 8/8 hrs for seven days. None patients was alergic to 
the medications.
All patients enrolled in the study gave their informed consent 
for the procedure.
Osteogenic Alveolar Distraction Technique:
The patients were asked to rinse their mouth with 0.12% 
Clorhexidine Gluconate before the procedure. Local anes-
thesia was administered (Lidocaine 2% with epinefrine 
1:100.000) in the area to be operated. 
A horizontal incision was made in the vestibulum, after 
which a buccal mucoperiosteal flap elevation was perfor-
med to expose the lateral cortex, without elevation of the 
crestal mucosa. Prebending and adaptation of the distractor 
device were initially performed before the osteotomies. The 
transport segment was cut into an inverted trapezoidal shape 
with diamond discs, sagittal saws and chisels. 
The transport segment was totally mobilized, although it 
remained attached to the lingual mucoperiosteum. After 
this, the distractor was positioned and fixed in place with 
1.5 mm monocortical screws. 
Variations in size of the transport disk and distractor device 
occurred according with each case. The device was activated 
to test for transported bone without interferences. The system 
was returned to its initial position and the flap was closed with 
4.0 Vycril suture (Johnson & Johnson, Ethicon, Brazil).
A waiting period of 7 days was allowed with a rate of 0.33 
mm every 8 hours (1 mm per day) for 6 to 12 days, accor-
ding to the plan for each particular case. After 90 days, the 
distractor was removed and the implants were placed du-
ring the same surgery. If  additional bone grafting was need 
to gain bone width, the procedure was made at that time 
and the implant placement was performed 5 months later. 
After 6 months of the implants’ placement, the prosthetic 
restoration was performed.
Clinical follow-up examinations were performed at 7,10, 15, 
20, 30, 60 and 90 days. The follow–up examination included 
a search for complications such as infection, tipping of the 
transport disk, paresthesias, epithelium invagination and/or 
fracture of transport disk or  the transport plate. After 90 
days, the device was removed and implants were placed. If  
additional width was required, bone grafting was performed 
at the tiem of device removal and implants were placement 
5 months later. In all implant cases 6 months after implant 
placement, the prosthetic restoration was delivered.
EVALUATION CRITERIA
The patient’s perception of the events during and after the 
osteogenic alveolar distraction (OAD) was evaluated.
Ten (10) questions about the treatment were made, five (5) 
of them making reference to predefined values in a Visual 
Analogic Scale (VAS). The scale was 10 cm long, one end 
corresponding to no pain or disconfort, the other to extreme 
pain or discomfort, and it was divided in 10 equal parts. 
Four (4) questions could be answered by predetermined 
answers with only one (1) question having a free answer. 
The questionnaire made to the patiens was:
1: How do you describe the sensation feeling during the 
surgery to put the device?
2: How do you describe the pain or disconfort feeling after 
the surgery, before the activation period?
3: Did you feel pain when the device was activated?
4: If  you feel pain, what medication did you take? (free 
answer)
5: How much time approximately in minutes have pain?
(   ) 10 min    (   ) 20 min    (   ) 30 min
6: Whats the better word to describe the feeling felt after 
each activation?
(   )Pain     (   )Discomfort   (   )Pressure    (   )None
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7: Did you feel any difficulty to activate the device three 
times daily?
8: How uncomfortable it was the presence of the activation 
rod in the mouth
during this period?
9: In case of being necessary it would make the surgery 
again?
(     ) Yes  (     ) No
In those cases were necessary a bone graft procedure, was 
made the next question: 
10: If  you make another surgical procedure like bone graft, 
how it would
compare it to alveolar distraction osteogenesis?
(   ) Worst    (   ) Worse    (   ) Same    (   ) Better   (   ) Much 
better
RESULTS
There were made 50 questionaries. In 76% of cases, the 
patient’s description of the sensation felt during the surgery 
was good and bearable (Fig. 1); 84% of the patients didn’t 
feel pain after surgery. 4% of the patients felt pain during 
the activation period and 58% of the patients described the 
sensation during the activation period as pressure (Fig.2), 
felt most commonly, at the end of the period, and for about 
20 minutes (66.6 %). In these cases the most frequently used 
analgesic was Paracetamol (84.5%).
Also, 46% expressed having had some difficulty to activate 
the device, with 10% of them in need of extra help (Fig.3). 
The presence of the activation rod caused discomfort in 
52% . Finally, 78% of the patients treated with OAD would 
undergo this procedure again if  it was necessary.
A bone graft was performed in 27 out of the 50 treated pa-
tients, with 70% of them describing the bone graft surgery 
as more painful than the OAD.
DISCUSSION
Osteogenic distraction (OD) is a technique of gradual bone 
lengthening that allows the body’s natural mechanisms to 
create new bone (20). The OAD is a relative new method that, 
compared with onlay grafts or guided bone regeneration, has 
showed a lower morbility rate, better previsibility, less bone 
resorption and it also enable the lengthening of the soft tissues 
and vessels by histogenesis (9,10). Compared with other rege-
neration techniques, the OAD a shorter treatment time because 
the distracted segments are well formed in just 12 weeks (9).
The severity of the pain is one of the chief  indicators of 
the patient’s comfort during the postoperative period after 
the OD. In this study we evaluated the degree of pain and 
discomfort felt during the operative and postoperative 
period using the VAS scale, wich is considerated to be an 
efficient tool to evaluate clinical parameters that influence 
the subjetive experience of an individual, such as pain.
The use of VAS was proposed by Henrikson et al. (21) to 
measure swelling, and compared the effects of two drugs on 
the postoperative period following a third molar extraction 
surgery. 
Fig. 1. How would you describe the sensation felt during the surgery 
to place the device?.
Fig. 2. What would be the better word to describe the sensation felt 
after each activation?.
Fig. 3. Did you have any difficulty to activate the device three 
times daily? .
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Berge (22), compared VAS’ scale valves to three-dimensional 
mechanical measumerents of swelling using an extra-oral 
cephalostat, and concluded that the VAS scale is a reliable 
and respectable method.
The ability of  the surgeon might influence the outcome 
of the surgery; based in this fact, only one surgeon was 
involved in this study. The obtained results indicate that 
the  majority of the patients tolerated well the surgery to 
place the distractor and the next seven postoperative days. 
Conscious sedation with Midazolam 15 mg 1 hour before 
the surgery and specific drugs to control postoperative pain 
and swelling were used. 
During the distraction period, 38 patients described an un-
comfortable feeling of pressure, similar to that experienced 
during orthodontic movements, and 9 patients felt pain 
that was controlled with an analgesic drug. In those cases 
the pain and tension don’t persist more than 20 minutes, as 
described by Gaggl et al. (13,14) and  Urbani et al. (16,17). 
In the rest of the cases, the patients didn’t describe any kind 
of sensation during the distraction period.
We agree that the presence of the device in the area for a 
long time including a healing, distraction and consolidation 
period can cause discomfort to the patients during function, 
as described by Oda et al. (23) and Papageorge (19). In our 
study, 17 patients referred discomfort caused by the presence 
of the device, especially in the anterior maxillary region. In 
the present study only in one case it was necessary to remove 
the device after 4 weeks because of the strong discomfort 
felt by the patient (15). 
Ten patients related having had problems with the acti-
vation of the device, three of them in need of extra help 
to activate it. In just one case the patient did not comply 
with the instructions to activate the device, performing the 
device activation in counterclockwise sense, compromising 
the result of the treatment. This situation can be compared 
with the study made by Van Strijen (18), where the pos-
sible complications during the osteogenic distraction of 
the mandible were evaluated, concluding that the patient’s 
compliance during the entire treatment period is essential, 
and thus careful patient selection is of outmost importance. 
Extensive pretreatment information should be provided to 
prevent unpleasant and disappointing results for patients 
and surgeon.
CONCLUSION
The technique of OAD had a high degree acceptance among 
the treated patients included in this study. However, some 
minor problems, as the interference of the activation rod, 
continue to disturb the patient. The acceptance of the OAD 
technique is much better when compared with bone grafts 
surgery.  
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